AtaiBeckley (ATAI) Reports 2025 Results and Q2 2026 Phase 3 Launch for BPL-003 [Yahoo! Finance]
AtaiBeckley Inc. (ATAI)
US:NASDAQ Investor Relations:
ir.atai.net.cn
Company Research
Source: Yahoo! Finance
AtaiBeckley Inc. (NASDAQ: ATAI ) is one of the best new penny stocks to buy . On March 6, AtaiBeckley reported full-year 2025 earnings, which were highlighted by the pivotal execution phase following the strategic combination of Atai Life Sciences and Beckley Psytech and its subsequent US redomiciliation. A primary focus is the BPL-003 nasal spray for treatment-resistant depression/TR, which is on track to initiate a Phase 3 pivotal program in Q2 2026. This program, supported by the FDA, will include two major studies, ReConnection-1 and ReConnection-2, with topline results anticipated by early 2029. The company also reported positive clinical progress across its broader pipeline, including the VLS-01 buccal film and EMP-01 for Social Anxiety Disorder/SAD. VLS-01 is expected to yield Phase 2 topline data in H2 2026. Meanwhile, an exploratory Phase 2a trial of EMP-01 successfully met its primary safety objectives and showed clinically meaningful improvements in efficacy measures. To
Show less
Read more
Impact Snapshot
Event Time:
ATAI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATAI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATAI alerts
High impacting AtaiBeckley Inc. news events
Weekly update
A roundup of the hottest topics
ATAI
News
- BPL-003 Phase 3 Program Initiation on Track for Q2 2026 Following Successful FDA End-of-Phase 2 Meeting; AtaiBeckley Highlights Key Pipeline Milestones at 2026 Investor DayGlobeNewswire
- CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA DecisionsPR Newswire
- AtaiBeckley reports 2025 results as it eyes Q2 start for Phase 3 depression trial [Yahoo! Finance]Yahoo! Finance
- AtaiBeckley Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business and Clinical Update [Yahoo! Finance]Yahoo! Finance
- AtaiBeckley Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business and Clinical UpdateGlobeNewswire
ATAI
Earnings
- 11/12/25 - Miss
ATAI
Sec Filings
- 3/13/26 - Form 4
- 3/13/26 - Form 3
- 2/26/26 - Form 144
- ATAI's page on the SEC website